Tg Therapeutics (TGTX) Operating Income Growth (3y) (2014 - 2026)
Tg Therapeutics (TGTX) Operating Income Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 16.96% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 38.78% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 13.47% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -12.10% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 69.02% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Tg Therapeutics | 8.10 Bn | 8.03 Bn | 171.41 Mn | 43.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.27% |
| Dec 31, 2025 | 38.40% |
| Sep 30, 2025 | 41.61% |
| Jun 30, 2025 | 42.52% |
| Mar 31, 2025 | 28.64% |
| Dec 31, 2024 | 32.42% |
| Sep 30, 2024 | 28.99% |
| Jun 30, 2024 | 28.34% |
| Mar 31, 2024 | 52.99% |
| Dec 31, 2023 | 47.60% |
| Sep 30, 2023 | 49.47% |
| Jun 30, 2023 | 4.22% |
| Mar 31, 2023 | 9.70% |
| Dec 31, 2022 | -26.88% |
| Sep 30, 2022 | 16.87% |
| Jun 30, 2022 | -3.09% |
| Mar 31, 2022 | -24.46% |
| Dec 31, 2021 | -19.73% |
| Sep 30, 2021 | -35.36% |
| Jun 30, 2021 | -55.33% |